San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, Human Longevity Inc. is raising $30,032,965.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, David Karow played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Human Longevity Inc.

Human Longevity, Inc. is the genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine.

To learn more about Human Longevity Inc., visit http://www.humanlongevity.com/

Contact:
David Karow, Chief Executive Officer
844-838-3322
dkarow@humanlongevity.com
https://www.linkedin.com/in/david-karow-304b3a143/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved